{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T21:32:37Z","timestamp":1757626357871,"version":"3.44.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"DOI":"10.1186\/s12877-025-06298-6","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T06:46:23Z","timestamp":1756104383000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Causal effect of conventional anti-dementia drugs on economic burden: an orthogonal double\/debiased machine learning approach"],"prefix":"10.1186","volume":"25","author":[{"given":"Xiangxiang","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan","family":"Franklin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z. Kevin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"key":"6298_CR1","unstructured":"Changes to Medicare Part D in 2024 and 2025 Under the Inflation Reduction Act and How Enrollees Will Benefit. KFF. Updated April 20. 2023. Accessed December 10, 2024. https:\/\/www.kff.org\/medicare\/issue-brief\/changes-to-medicare-part-d-in-2024-and-2025-under-the-inflation-reduction-act-and-how-enrollees-will-benefit\/"},{"key":"6298_CR2","unstructured":"New Alzheimer\u2019s Drugs Spark Hope for Patients and Cost Concerns for Medicare. KFF. Updated July 6, 2023. Accessed. December, 2024. https:\/\/www.kff.org\/policy-watch\/new-alzheimers-drugs-spark-hope-for-patients-and-cost-concerns-for-medicare\/"},{"key":"6298_CR3","doi-asserted-by":"crossref","unstructured":"2023 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. Apr 2023;19(4):1598\u20131695.","DOI":"10.1002\/alz.13016"},{"key":"6298_CR4","doi-asserted-by":"crossref","unstructured":"2024 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. May 2024;20(5):3708\u20133821.","DOI":"10.1002\/alz.13809"},{"issue":"suppl1","key":"6298_CR5","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1093\/geront\/gnx147","volume":"18","author":"MG Austrom","year":"2018","unstructured":"Austrom MG, Boustani M, LaMantia MA. Ongoing medical management to maximize health and Well-being for persons living with dementia. Gerontologist Jan. 2018;18(suppl1):S48\u201357.","journal-title":"Gerontologist Jan"},{"key":"6298_CR6","doi-asserted-by":"crossref","unstructured":"Chen ZR, Huang JB, Yang SL et al. Role of Cholinergic Signaling in Alzheimer\u2019s Disease. Molecules 2022;27(6).","DOI":"10.3390\/molecules27061816"},{"issue":"Suppl 3","key":"6298_CR7","doi-asserted-by":"publisher","first-page":"S312","DOI":"10.4103\/0019-5545.224472","volume":"60","author":"KS Shaji","year":"2018","unstructured":"Shaji KS, Sivakumar PT, Rao GP, et al. Clinical practice guidelines for management of dementia. Indian J Psychiatry Feb. 2018;60(Suppl 3):S312\u201328.","journal-title":"Indian J Psychiatry Feb"},{"issue":"6","key":"6298_CR8","doi-asserted-by":"publisher","first-page":"746","DOI":"10.2174\/156720512801322564","volume":"9","author":"D Olivares","year":"2012","unstructured":"Olivares D, Deshpande VK, Shi Y, et al. N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for alzheimer\u2019s disease, vascular dementia and parkinson\u2019s disease. Curr Alzheimer Res Jul. 2012;9(6):746\u201358.","journal-title":"Curr Alzheimer Res Jul"},{"issue":"2","key":"6298_CR9","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.amjopharm.2005.07.001","volume":"3","author":"S Lu","year":"2005","unstructured":"Lu S, Hill J, Fillit H. Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer\u2019s disease and related dementias enrolled in a large Medicare managed care plan: a case-control study. Am J Geriatr Pharmacother. 2005;3(2):92\u2013102.","journal-title":"Am J Geriatr Pharmacother"},{"issue":"10","key":"6298_CR10","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1017\/S104161021800011X","volume":"30","author":"S Behrens","year":"2018","unstructured":"Behrens S, Rattinger GB, Schwartz S, et al. Use of FDA approved medications for alzheimer\u2019s disease in mild dementia is associated with reduced informal costs of care. Int Psychogeriatr Oct. 2018;30(10):1499\u2013507.","journal-title":"Int Psychogeriatr Oct"},{"issue":"4","key":"6298_CR11","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/1475-6773.13134","volume":"54","author":"L White","year":"2019","unstructured":"White L, Fishman P, Basu A, et al. Medicare expenditures attributable to dementia. Health Serv Res Aug. 2019;54(4):773\u201381.","journal-title":"Health Serv Res Aug"},{"issue":"7","key":"6298_CR12","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jval.2022.03.022","volume":"25","author":"WV Padula","year":"2022","unstructured":"Padula WV, Kreif N, Vanness DJ, et al. Machine learning methods in health economics and outcomes research-the PALISADE checklist: a good practices report of an ISPOR task force. Value Health. 2022;25(7):1063\u201380.","journal-title":"Value Health"},{"key":"6298_CR13","unstructured":"Medicare Current Beneficiary Survey (MCBS). Centers for Medicare & Medicaid Services (CMS). Updated November 27, 2023. Accessed November 30. 2023. https:\/\/www.cms.gov\/data-research\/research\/medicare-current-beneficiary-survey"},{"issue":"1","key":"6298_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3233\/JAD-190310","volume":"72","author":"J Thunell","year":"2019","unstructured":"Thunell J, Ferido P, Zissimopoulos J. Measuring alzheimer\u2019s disease and other dementias in diverse populations using medicare claims data. J Alzheimers Dis. 2019;72(1):29\u201333.","journal-title":"J Alzheimers Dis"},{"key":"6298_CR15","unstructured":"Health Disparities Framework. National Institute on Aging (NIA) Accessed December 10. 2024. https:\/\/www.nia.nih.gov\/research\/osp\/framework"},{"issue":"1","key":"6298_CR16","doi-asserted-by":"publisher","first-page":"C1","DOI":"10.1111\/ectj.12097","volume":"21","author":"V Chernozhukov","year":"2018","unstructured":"Chernozhukov V, Chetverikov D, Demirer M, et al. Double\/debiased machine learning for treatment and structural parameters. Econometrics J. 2018;21(1):C1\u201368.","journal-title":"Econometrics J"},{"issue":"47","key":"6298_CR17","doi-asserted-by":"publisher","first-page":"14473","DOI":"10.1073\/pnas.1515373112","volume":"24","author":"S Yang","year":"2015","unstructured":"Yang S, Santillana M, Kou SC. Accurate Estimation of influenza epidemics using Google search data via ARGO. Proc Natl Acad Sci U S A Nov. 2015;24(47):14473\u20138.","journal-title":"Proc Natl Acad Sci U S A Nov"},{"issue":"12","key":"6298_CR18","doi-asserted-by":"publisher","first-page":"e1004124","DOI":"10.1371\/journal.pmed.1004124","volume":"19","author":"S Chen","year":"2022","unstructured":"Chen S, Price AC, Cardinal RN, et al. Association between antidementia medication use and mortality in people diagnosed with dementia with lewy bodies in the UK: A retrospective cohort study. PLoS Med Dec. 2022;19(12):e1004124.","journal-title":"PLoS Med Dec"},{"issue":"6","key":"6298_CR19","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1212\/WNL.52.6.1138","volume":"12","author":"PJ Neumann","year":"1999","unstructured":"Neumann PJ, Hermann RC, Kuntz KM, et al. Cost-effectiveness of donepezil in the treatment of mild or moderate alzheimer\u2019s disease. Neurology Apr. 1999;12(6):1138\u201345.","journal-title":"Neurology Apr"},{"issue":"21","key":"6298_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta16210","volume":"16","author":"M Bond","year":"2012","unstructured":"Bond M, Rogers G, Peters J, et al. The effectiveness and cost-effectiveness of donepezil, galantamine, Rivastigmine and memantine for the treatment of alzheimer\u2019s disease (review of technology appraisal 111): a systematic review and economic model. Health Technol Assess. 2012;16(21):1\u2013470.","journal-title":"Health Technol Assess"},{"key":"6298_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2377-12-2","volume":"8","author":"S Hartz","year":"2012","unstructured":"Hartz S, Getsios D, Tao S, et al. Evaluating the cost effectiveness of donepezil in the treatment of alzheimer\u2019s disease in Germany using discrete event simulation. BMC Neurol Feb. 2012;8:12:2.","journal-title":"BMC Neurol Feb"},{"issue":"5","key":"6298_CR22","doi-asserted-by":"publisher","first-page":"411","DOI":"10.2165\/11531870-000000000-00000","volume":"28","author":"D Getsios","year":"2010","unstructured":"Getsios D, Blume S, Ishak KJ, et al. Cost effectiveness of donepezil in the treatment of mild to moderate alzheimer\u2019s disease: a UK evaluation using discrete-event simulation. PharmacoEconomics. 2010;28(5):411\u201327.","journal-title":"PharmacoEconomics"},{"issue":"10","key":"6298_CR23","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1111\/cns.13035","volume":"24","author":"A Adlimoghaddam","year":"2018","unstructured":"Adlimoghaddam A, Neuendorff M, Roy B, et al. A review of clinical treatment considerations of donepezil in severe alzheimer\u2019s disease. CNS Neurosci Ther Oct. 2018;24(10):876\u201388.","journal-title":"CNS Neurosci Ther Oct"},{"issue":"8","key":"6298_CR24","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/MLR.0000000000001577","volume":"1","author":"PJ Lin","year":"2021","unstructured":"Lin PJ, Daly AT, Olchanski N, et al. Dementia diagnosis disparities by race and ethnicity. Med Care Aug. 2021;1(8):679\u201386.","journal-title":"Med Care Aug"},{"issue":"7","key":"6298_CR25","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1177\/0898264318767778","volume":"31","author":"M Rivera-Hernandez","year":"2019","unstructured":"Rivera-Hernandez M, Kumar A, Epstein-Lubow G, et al. Disparities in nursing home use and quality among African american, hispanic, and white medicare residents with alzheimer\u2019s disease and related dementias. J Aging Health Aug. 2019;31(7):1259\u201377.","journal-title":"J Aging Health Aug"},{"issue":"1","key":"6298_CR26","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1186\/s12877-020-01888-y","volume":"18","author":"S Park","year":"2020","unstructured":"Park S, Chen J. Racial and ethnic patterns and differences in health care expenditures among medicare beneficiaries with and without cognitive deficits or alzheimer\u2019s disease and related dementias. BMC Geriatr Nov. 2020;18(1):482.","journal-title":"BMC Geriatr Nov"},{"issue":"1","key":"6298_CR27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12939-025-02401-w","volume":"7","author":"AM Chen","year":"2025","unstructured":"Chen AM. Barriers to health equity in the united States of america: can they be overcome? Int J Equity Health Feb. 2025;7(1):39.","journal-title":"Int J Equity Health Feb"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-025-06298-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-025-06298-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-025-06298-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T22:08:32Z","timestamp":1757455712000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-025-06298-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6298"],"URL":"https:\/\/doi.org\/10.1186\/s12877-025-06298-6","relation":{},"ISSN":["1471-2318"],"issn-type":[{"type":"electronic","value":"1471-2318"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"assertion":[{"value":"15 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The University of South Carolina Institutional Review Board approved this study. Because we used deidentified data from the Medicare Current Beneficiary Survey (MCBS), the University of South Carolina Institutional Review Board has waived the need for informed consent for this study. Specifically, the Office of Research Compliance, on behalf of the Institutional Review Board, approved the referenced study. This study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"659"}}